“The risk of malpractice within the specialty is real, and in some respect, inevitable for most of us,” wrote Jonathan L. Mezrich, MD, in a new piece published by the American Journal of Roentgenology.

The American Society of Radiologic Technologists (ASRT) has announced numerous award winners, selecting members for a variety of honors. 

CMS wants to reduce the paperwork burden for the healthcare industry and is asking for stakeholder input on its initiative, Patients over Paperwork, the agency announced June 6.

Imaging providers are implementing new and creative ways to improve breast cancer screening at their facilities, including holding special V.I.P. nights and offering services from within a shopping mall.

The American Society for Radiation Oncology (ASTRO) is championing bipartisan legislation introduced Wednesday, June 5, that would reduce prior authorization practices found to delay patient access to necessary cancer treatments.

Half of all physicians in the United States experience burnout, and recent surveys have suggested that number could be even higher among women.

An updated cost-effectiveness analysis of evolocumab suggests that while treatment with the PCSK9 inhibitor may always be somewhat costly, it remains effective in hard-to-treat patients and its reduced list price meets cost-effectiveness thresholds across a range of CV events in patients with very-high-risk atherosclerotic CVD.

Drugmaker Pfizer hid that one of its powerful anti-inflammatory drugs for rheumatoid arthritis therapy, Enbrel, reduced the risk of Alzheimer’s disease by 64%, according to a report by the Washington Post.